Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Eye

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.eye.6702222PMID 16410809
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.

  2006cited by this paper
• Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

  2006cited by this paper
• Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.

  2005cited by this paper
• Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.

  2005cited by this paper
• Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.

  2005cited by this paper
• Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.

  2005cited by this paper
• Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo

  2005cited by this paper
• Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.

  2005cited by this paper
• Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.

  2005cited by this paper
• Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration

  2005cited by this paper
• Triamcinolone acetonide concentration after filtration of the solvent agent.

  2005cited by this paper
• The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization

  2005cited by this paper
• Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study

  2005cited by this paper
• Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect

  2005cited by this paper
• Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial.

  2004cited by this paper
• Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.

  2004cited by this paper
• Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.

  2004cited by this paper
• VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2004cited by this paper
• Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration

  2004cited by this paper
• Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration

  2004cited by this paper
• Pegaptanib for neovascular age-related macular degeneration.

  2004cited by this paper
• Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.

  2004cited by this paper
• Intravitreal Triamcinolone for refractory diabetic macular oedema.

  2004cited by this paper
• Pseudo-endophthalmitis after intravitreal injection of triamcinolone

  2003cited by this paper
• Intravitreal triamcinolone acetonide for exudative age related macular degeneration

  2003cited by this paper
• Noninfectious endophthalmitis associated with intravitreal triamcinolone injection.

  2003cited by this paper
• A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.

  2003cited by this paper
• Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes.

  2003cited by this paper
• Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

  2003cited by this paper
• Endophthalmitis after intravitreal injection of triamcinolone acetonide.

  2003cited by this paper
• Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide.

  2003cited by this paper
• Nontuberculous mycobacterial endophthalmitis.

  2003cited by this paper
• Nontuberculous Mycobacterial Endophthalmitis

  2003cited by this paper
• Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes

  2002cited by this paper
• Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration

  2002cited by this paper
• Intravitreal triamcinolone in recurrence of choroidal neovascularisation

  2002cited by this paper
• Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.

  2002cited by this paper
• Intravitreal triamcinolone for refractory diabetic macular edema.

  2002cited by this paper
• Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration

  2002cited by this paper
• Verteporfin in Photodynamic Therapy (VIP) Study group.

  2002cited by this paper
• Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C

  2002cited by this paper
• Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

  2001cited by this paper
• Regression of Neovascular Iris Vessels by Intravitreal Injection of Crystalline Cortisone

  2001cited by this paper
• Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy.

  2001cited by this paper
• Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.

  2001cited by this paper
• INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE‐RELATED MACULAR DEGENERATION

  2000cited by this paper
• Intravitreal triamcinolone and elevated intraocular pressure.

  1999cited by this paper
• Intravitreal triamcinolone and elevated intraocular pressure.

  1999cited by this paper
• Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

  1998cited by this paper
• Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.

  1996cited by this paper
• Five cases in which a depot steroid (hydrocortisone acetate and methylprednisolone acetate) was injected into the eye.

  1996cited by this paper
• Exudative macular degeneration and intravitreal triamcinolone. A pilot study.

  1995cited by this paper
• Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate.

  1985cited by this paper
• Inhibition of intraocular proliferations with intravitreal corticosteroids.

  1980cited by this paper
• Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide.

  1980cited by this paper
• Treatment of intraocular proliferations with intravitreal steroids.

  1979cited by this paper

• The Role of Inflammation in Age-Related Macular Degeneration.

  2025cites this paper
• Mitteilungen der DOG

  2024cites this paper
• The Use of Neuroprotective Agents in Treating Geographic Atrophy

  2021cites this paper
• Mitteilungen der DOG

  2020cites this paper
• Efficacy and Safety of Combined Intravitreal Bevacizumab and Retrobulbar Corticosteroids for Neovascular Age-Related Macular Degeneration

  2017cites this paper
• Uloga kortikosteroida u liječenju makularnih bolesti

  2015cites this paper
• Intraocular pressure monitoring post intravitreal steroids: a systematic review.

  2013cites this paper
• Treatment of metastatic and primary uveal melanoma

  2012cites this paper
• Therapie der choroidalen Neovaskularisation mit Anti- VEGF Inhibitoren. Langzeitergebnisse und prognostische Faktoren

  2012cites this paper
• The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

  2011cites this paper
• Intravitreal Triamcinolone

  2010cites this paper
• Pharmacotherapeutic efficacy of preservative-free intravitreal triamcinolone acetonide

  2010cites this paper
• Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth

  2008cites this paper
• Intravitreal Bevacizumab versus Triamcinolone Acetonide for Exudative Age-Related Macular Degeneration

  2008cites this paper
• Laserfotokoagulation und photodynamische Therapie (PDT) zur Behandlung der retinalen angiomatösen Proliferation (RAP) bei feuchter altersabhängiger Makuladegeneration (AMD)

  2008cites this paper
• Stellungnahme der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft und des Berufsverbands der Augenärzte Deutschlands zu aktuellen therapeutischen Möglichkeiten bei der neovaskulären altersabhängigen Makuladegeneration

  2007cites this paper
• PROSPECTIVE, RANDOMIZED CLINICAL TRIAL OF INTRAVITREAL TRIAMCINOLONE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: One-Year Results

  2007cites this paper
• Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops

  2007cites this paper
• Ocular Photodynamic Therapy – Standard Applications and New Indications (Part 2)

  2007cites this paper
• Stellungnahme zu aktuellen therapeutischen M glichkeiten bei der neovaskul ren

  2006cites this paper
• Intravitreal Triamcinolone Acetonide: A Change in a Paradigm

  2006cites this paper
• Visual Acuity Change After Intravitreal Triamcinolone in Various Types of Exudative Age-Related Macular Degeneration

  2006cites this paper
• Stellungnahme zu aktuellen therapeutischen Möglichkeiten bei der neovaskulären altersabhängigen Makuladegeneration

  2006cites this paper